We serve Chemical Name:Methyl 3-(CyclopropylaMino)propanoate CAS:77497-84-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Methyl 3-(CyclopropylaMino)propanoate
CAS.NO:77497-84-8
Synonyms:Methyl 3-(CyclopropylaMino)propanoate;Methyl 3-cyclopropylaminopropionate
Molecular Formula:C7H13NO2
Molecular Weight:143.18400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:214.2±23.0 ºC (760 Torr)
Density:1.04±0.1 g/cm3
Index of Refraction:
PSA:38.33000
Exact Mass:143.09500
LogP:0.69240
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like Methyl 3-(CyclopropylaMino)propanoate chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Methyl 3-cyclopropylaminopropionate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Methyl 3-(CyclopropylaMino)propanoate Use and application,Methyl 3-(CyclopropylaMino)propanoate technical grade,usp/ep/jp grade.
Related News: However, to leverage these benefits, it is vital that biocatalytic processes be evaluated as early in the drug development life cycle as possible. Fortunately, the growing availability of diverse kits of enzyme classes can facilitate this process, allowing researchers to screen enzymes/biocatalysts in much the same way as traditional screening of metal catalysts is performed. di-n-butyltin bis(2-ethylhexanoate) manufacturers Charles River Laboratories and AstraZeneca have maintained a strategic partnership since 2012, providing AstraZeneca with outsourced regulated safety and development support on a range of treatments and vaccines, including testing and facilitating the deployment of the vaccines Vaxzevria for COVID-19 and Fluenz for seasonal infleunza. Palbociclib hydrochloride suppliers The company was one of many to step into the void for needed generic medicines as chronic shortages crippled access to key drugs, specifically in the early- to mid-stages of the pandemic. That shortage actually led the FDA to thaw its relationship with compounding pharmacies — which was once particularly icy — to ramp up production. chlorimuron-ethyl vendor & factory.
